Evaluation of an AR-Assisted System for Standardizing Spirometry
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChina-Japan Friendship Hospital
About this trial
Spirometry is the gold-standard tool for diagnosing Chronic Obstructive Pulmonary Disease (COPD). However, its implementation in primary care is often limited by a shortage of qualified technicians and inconsistent testing quality. This study will use Augmented Reality (AR) glasses to provide real-time interaction and guidance to participants during spirometry. It will be designed as a two-phase study to evaluate the technical validity and clinical effectiveness of AR-assisted spirometry (AR-SPIRO) system.
Eligibility criteria
Qualifiers
Age ≥ 18 years.
Able to provide written informed consent.
Age ≥ 40 years.
Cumulative smoking history of ≥10 pack-years or history of biomass fuel exposure for ≥10 years.
Disqualifiers
Presence of absolute or relative contraindications to spirometry.
Current pregnancy.
Severe vision or hearing impairments that preclude the effective use of Augmented Reality (AR) glasses.
Trial design
Treatments tested in this trial
- AR-Assisted Spirometry Guidance System
- Routine Technician-led Spirometry Guidance
Treatment groups
710 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov